Decoy Therapeutics (DCOY) Deferred Taxes (2015 - 2018)
Decoy Therapeutics (DCOY) posted quarterly Deferred Taxes of -$53919.0 for Q4 2018, down 266.67% year-over-year from $32350.5 in Q4 2017, and down 266.65% quarter-over-quarter from -$14706.0 in Q3 2018.
Decoy Therapeutics (DCOY) Deferred Taxes (2015 - 2018) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Deferred Taxes for 4 consecutive years, with -$53919.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Deferred Taxes fell 266.67% year-over-year to -$53919.0; the TTM figure through Jun 2019 stood at -$68625.0 (down 195.12% YoY), while the FY2018 annual figure was -$98035.0, down 243.03% from the prior year.
- Deferred Taxes fell to -$53919.0 in Q4 2018 per DCOY's latest filing, from -$14706.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $37197.0 in Q1 2017 and bottomed at -$53919.0 in Q4 2018.
- Historically, Deferred Taxes has averaged -$3615.6 across 4 years, with a median of -$5569.5 in 2015.
- Annual changes were most pronounced in 2017 — Deferred Taxes jumped 564.89% — and 2018, when it slumped 266.67%.
- Decoy Therapeutics' Deferred Taxes stood at -$5720.0 in 2015, then dropped by 12.22% to -$6419.0 in 2016, then sank by 129.09% to -$14705.0 in 2017, then plunged by 266.67% to -$53919.0 in 2018.
- Business Quant data shows DCOY's Deferred Taxes at -$53919.0 in Q4 2018, -$14706.0 in Q3 2018, and -$14705.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -53,919.00 |
| Sep 30, 2018 | -14,706.00 |
| Jun 30, 2018 | -14,705.00 |
| Mar 31, 2018 | -14,705.00 |
| Dec 31, 2017 | -14,705.00 |
| Sep 30, 2017 | 20,862.00 |
| Jun 30, 2017 | 25,188.00 |
| Mar 31, 2017 | 37,197.00 |
| Dec 31, 2016 | -6,419.00 |
| Sep 30, 2016 | -5,419.00 |
| Jun 30, 2016 | -5,418.00 |
| Mar 31, 2016 | 7,781.00 |
| Dec 31, 2015 | -5,720.00 |
| Sep 30, 2015 | -4,720.00 |
| Jun 30, 2015 | -2,221.00 |
| Mar 31, 2015 | -6,220.00 |